Intrafamilial transmission of extended-spectrum- -lactamase-producing Escherichia coli and Salmonella enterica Babelsberg among the families of internationally adopted children

Tandé, Didier; Boisramé, Sylvie; Münck, Marie-Reine; Héry-Arnaud, Geneviève; Gouriou, S.; Jallot, Nelle; Nordmann, Patrice; Naas, Thierry

doi:10.1093/jac/dkq068

Cited by 59 publications

(45 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This contrasts with the mean carriage duration of 6.6 months in patients who were colonized during hospitalization (94). However, carriage can be far more prolonged in travelers with diarrhea or exposed to antibiotics while abroad (93,95) and in native African children arriving in Europe after adoption (96).…”

Section: Travelersmentioning

confidence: 87%

“…In China, the carriage rates were higher in families with at least one individual with a history of out-of-town residence and were inversely correlated with living space (98). Finally, transmission of ESBL-E within the family does not seem to be limited to E. coli but may also occur for other enterobacteria, such as Salmonella (96).…”

Section: Dissemination Routes Strain Diversity and Transmissionmentioning

confidence: 94%

See 1 more Smart Citation

Trends in Human Fecal Carriage of Extended-Spectrum β-Lactamases in the Community: Toward the Globalization of CTX-M

et al. 2013

View full text Add to dashboard Cite

SUMMARY In the last 10 years, extended-spectrum β-lactamase-producing enterobacteria (ESBL-E) have become one of the main challenges for antibiotic treatment of enterobacterial infections, largely because of the current CTX-M enzyme pandemic. However, most studies have focused on hospitalized patients, though today it appears that the community is strongly affected as well. We therefore decided to devote our investigation to trends in ESBL-E fecal carriage rates and comprehensively reviewed data from studies conducted on healthy populations in various parts of the world. We show that (i) community ESBL-E fecal carriage, which was unknown before the turn of the millennium, has since increased significantly everywhere, with developing countries being the most affected; (ii) intercontinental travel may have emphasized and globalized the issue; and (iii) CTX-M enzymes, especially CTX-M-15, are the dominant type of ESBL. Altogether, these results suggest that CTX-M carriage is evolving toward a global pandemic but is still insufficiently described. Only a better knowledge of its dynamics and biology will lead to further development of appropriate control measures.

show abstract

Section: Travelersmentioning

confidence: 87%

Section: Dissemination Routes Strain Diversity and Transmissionmentioning

confidence: 94%

Trends in Human Fecal Carriage of Extended-Spectrum β-Lactamases in the Community: Toward the Globalization of CTX-M

et al. 2013

View full text Add to dashboard Cite

show abstract

“…Our data are in agreement with previous studies, which found a prevalence of multidrug-resistant bacteria in adults from developing countries. 7,8,25 The hypotheses for this prevalence are frequent self-medication with poor quality drugs that are given without control by the health authorities and inadequate drug dosage or treatment duration.…”

Section: Discussionmentioning

confidence: 99%

Frequency and Characteristics of Infectious Diseases in Internationally Adopted Children: A Retrospective Study in Nantes From 2010 to 2012

Henaff¹,

Hazart

Picherot

et al. 2015

J Travel Med

View full text Add to dashboard Cite

show abstract

“…[21][22][23][78][79][80][81][82][83][84][85][86][87][88][89][90] Most studies were conducted in the acute-care setting [21][22][23][79][80][81]83,85,87,[89][90][91] and identified a population of patients infected and/or colonized with MDR-E, either ESBL-E or CRE, or MDR-Enterobacteriaceae defined by resistance to multiple classes of drugs. Patients were assessed for persistence of colonization at study-specific intervals and variable durations of follow-up.…”

Section: Duration Of Colonizationmentioning

confidence: 99%

Duration of Contact Precautions for Acute-Care Settings

Banach

Bearman

Barnden³

et al. 2018

Infect. Control Hosp. Epidemiol.

View full text Add to dashboard Cite

purposeThis expert guidance document (EG) provides recommendations regarding discontinuation of contact precautions (CP) at the individual patient level in acute-care hospitals employing CP for 1 or more of the following organisms: methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), Clostridium difficile, and multidrug-resistant Enterobacteriaceae (MDR-E), including carbapenem-resistant Enterobacteriaceae (CRE) and extended-spectrum β-lactamase (ESBL)-producing organisms. This document also provides a review of the role of molecular testing in guiding decisions pertaining to duration of CP for patients with these organisms. The guidance does not address decisions regarding the initiation of CP for any specific organism.Previously published guidelines describe components of CP and identify situations in which CP should be used; currently, however, few publications address the issue of how long CP should be maintained. At the time of publication, decisions related to implementation of CP for select, endemic organisms are made by individual facilities based on factors such as institutional epidemiology, resources, organizational priorities, and previously published guidance, and these vary widely. The SHEA Guidelines Committee (GLC) selected this topic to address when CP should be discontinued for individual patients in acute-care settings that employ CP for the aforementioned organisms.Although the organisms addressed are frequently encountered in other settings (eg, nursing homes, long-term acute-care facilities, rehabilitation centers, outpatient medical care settings), additional considerations may affect the application of these recommendations outside the acute-care hospital environment. authorsThe authors consist of current and past members of the SHEA Guidelines Committee (GLC), who serve as volunteers. All authors are involved at their respective institutions in the development of policies pertaining to CP, either directly or in an advisory role. intended useSpecial-topic EG documents are developed to address areas of relatively narrow scope that lack the level of evidence required for a formal guideline but are important for the provision of safe and effective healthcare. As such, systematic grading of evidence level is not provided for individual recommendations. Each EG is based on a synthesis of limited evidence, theoretical rationale, current practices, practical considerations, the opinion of the writing group, and consideration of potential harms where applicable. Within the EG, a summary list of recommendations is provided, along with their respective rationales. We also conducted a survey of the SHEA Research Network (SRN).No EG can anticipate all situations and this EG is not meant to be a substitute for individual judgment by qualified professionals. methods Expert Guidance DevelopmentThis EG follows the process outlined in the Handbook for SHEA-Sponsored Guidelines and Expert Guidance Documents. 10 The topic of duration of CP was among those proposed and ...

show abstract

Intrafamilial transmission of extended-spectrum- -lactamase-producing Escherichia coli and Salmonella enterica Babelsberg among the families of internationally adopted children

Cited by 59 publications

References 31 publications

Trends in Human Fecal Carriage of Extended-Spectrum β-Lactamases in the Community: Toward the Globalization of CTX-M

Trends in Human Fecal Carriage of Extended-Spectrum β-Lactamases in the Community: Toward the Globalization of CTX-M

Frequency and Characteristics of Infectious Diseases in Internationally Adopted Children: A Retrospective Study in Nantes From 2010 to 2012

Duration of Contact Precautions for Acute-Care Settings

Contact Info

Product

Resources

About